MedTrace Logo

Health-Related Quality of Life and Metabolic Outcomes in PCOS

NCT07571915 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-07-01

No results posted yet for this study

Summary

The primary outcome of interest is change in PCOS health-related quality of life, while the secondary outcome of interest is change in adiposity, cardiometabolic, and inflammation biomarkers.

Conditions

  • PCOS (Polycystic Ovary Syndrome)

Interventions

OTHER

Intervention Group

Short term comprehensive PCOS education coupled with lifestyle modification support

Sponsors & Collaborators

  • American Academy of Family Physicians

    collaborator OTHER

  • The Cleveland Clinic

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2027-05-01
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07571915 on ClinicalTrials.gov